Retraction

PI3K/Akt pathway and Nanog maintain cancer stem cells in sarcomas

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1038/s41389-024-00519-0
Additional Notes:

see also: https://pubpeer.com/publications/A03A70ADBD15AB9F1B2673A69C7DA9

Citations (54)

54
Total Citations
10
Post-Retraction
(18.5%)
44
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
10 Within 1 year
0 After 2+ years
307 Days since retraction (latest)
Abnormal Glycosylation of Cancer Stem Cells and Targeting Strategies
Thahomina Khan, Horacio Cabral
Frontiers in Oncology Open Access
Published: Apr 2021
24 citations
1149 days before retraction
Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
Zengyu Feng, Kexian Li, Yulian Wu et al. (4 authors)
Frontiers in Molecular Biosciences Open Access
Published: Mar 2021
12 citations
1163 days before retraction
Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion
Wang Gong, Christopher R. Donnelly, Blake R. Heath et al. (16 authors)
OncoImmunology Open Access
Published: Jan 2021
41 citations
1244 days before retraction
Non-flavonoids Targeting Cancer Stem Cells: A Promising Therapeutic Avenue for Cancer Treatment
Faizan Uddin, Mehboob Hoque
Springer eBooks
Published: Jan 2021
5 citations
1244 days before retraction